Factors Associated With Clinical Outcomes in Patients Hospitalized for Covid-19 in GHT-93 Est
NCT ID: NCT04366206
Last Updated: 2020-04-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
143 participants
OBSERVATIONAL
2020-03-14
2020-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This cohort study aims to assess factors associated with clinical outcomes in patients hospitalized for Covid-19, by analyzing associations between treatments and outcomes.
All data are collected in electronical records during routine practice.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Treatments in Patients Hospitalized for Severe COVID-19 Pneumonia: a Multicenter Cohort Study
NCT04365764
Host-pathogen Interactions During SARS-CoV-2 Infection
NCT04376476
Role of the Microbiota in the Evolution of the SARS-CoV-2 Disease,COVID-19, in Hospitalized Patients
NCT04669938
Education of Medical Staff to Post Acute Covid susTained sYmptoms
NCT06082258
Risk Factors Worsening COVID19 for Out-patient With Home Monitoring
NCT04380662
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This cohort study aims to assess factors associated with clinical outcomes in patients hospitalized for Covid-19.
Risk factors which will be studied include: baseline characteristics such as medical history and drugs with corresponding administration protocols.
Main outcomes include all-cause mortality, need for mechanical ventilation, for ICU transfer and all relevant biological syndromes.
All data are collected in electronical records during routine practice and additional data may be collected retrospectively.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients exposed to the study variable
Depending on the studied variable (treatment or risk factor)
No interventions assigned to this group
Patients not exposed to the study variable
Depending on the studied variable (treatment or risk factor)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* severe pneumonia defined as pulse O2 \< 96% despite \> 6L/min
Exclusion Criteria
* palliative care patients
* patients in ICU
* patients transferred from ICU
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Groupe Hospitalier Pitie-Salpetriere
OTHER
Centre Hospitalier Intercommunal Robert Ballanger
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Hélène GROS
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hélène Gros, MD
Role: STUDY_DIRECTOR
Robert Ballanger
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Intercommunal Robert Ballanger
Aulnay-sous-Bois, , France
Groupe Hospitalier Pitie Salpetriere
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GHTRB-2020-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.